Synne H Røine, new Chief Financial Officer Begins at Bionor Pharma Medio May
The Appointment Strengthens Bionor Pharma’s Management Team and Presence in the Financial Market
(Oslo, Norway 14 May 2013) Bionor Pharma ASA (OSE: BIONOR) today announced that Synne H Røine, who was announced 1 March as the Company’s new CFO, now will begin to work at Bionor Pharma.
Synne H Røine (33) has held the position as Chief Financial Officer of Pronova BioPharma ASA since July 2009, where she has played a key role in the financial team from the IPO in 2007 to the acquisition of the Company by BASF in January 2013.
For more information, see the release which was published 1 March 2013 regarding the appointment of Ms. Røine.
Bionor Pharma ASA
Hilde Aalling Syvertsen
-Director Communications & Corporate Affairs
Tel +47 23 01 09 60